United Therapeutics Corporation (UTHR)
Last Price$361.1(1.7%)
Market Cap$16.1B
Intrinsic value score
8/10
Great
Intrinsic value
$406.0
DCF value - $444.4
Relative value - $367.7
Undervalued
12.4%
LTM P/E
14.5x
Peer set median (30.5x)
Discount rate
7.5%
UTHR Intrinsic value
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
UTHR Historical Intrinsic Value
Crunching data... Almost there!
UTHR vs Peer Set: Intrinsic Value Comparison
Crunching data... Almost there!
Explore more intrinsic value tools hub for UTHR
Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value
FAQ
What is United Therapeutics Corporation intrinsic value?
As of Feb 21, 2025, United Therapeutics Corporation Intrinsic Value is $406.0. This suggests it may be undervalued by 12.4% compared to its current price of around $361.1.
What is United Therapeutics Corporation DCF (discounted cash flow) valuation?
As of Feb 21, 2025, United Therapeutics Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $440.2. This suggests it may be overvalued by 21.9% to its current price of around $361.1, using a discount rate of 7.5% and terminal growth rate of 3.0%.
Is United Therapeutics Corporation overvalued or undervalued?
United Therapeutics Corporation is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $406.0, compared to a market price of around $361.1. This suggests a potential undervaluation of 12.4%.